Source:http://linkedlifedata.com/resource/pubmed/id/18837144
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
14
|
| pubmed:dateCreated |
2008-10-3
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1533-4406
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
2
|
| pubmed:volume |
359
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1519-20; author reply 1520-1
|
| pubmed:meshHeading |
pubmed-meshheading:18837144-Cardiovascular Diseases,
pubmed-meshheading:18837144-Diabetes Mellitus, Type 2,
pubmed-meshheading:18837144-Drug Therapy, Combination,
pubmed-meshheading:18837144-Hemoglobin A, Glycosylated,
pubmed-meshheading:18837144-Humans,
pubmed-meshheading:18837144-Hypoglycemic Agents,
pubmed-meshheading:18837144-Thiazolidinediones
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Intensive glucose control in type 2 diabetes.
|
| pubmed:publicationType |
Letter,
Comment
|